A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers
- PMID: 38871993
- DOI: 10.1007/s11764-024-01627-x
A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers
Abstract
Purpose: Fertility preservation is the only option to safeguard fertility following gonadotoxic treatments. This study aimed to provide an updated status on fertility preservation for pediatric cancer patients in the Nordic countries.
Methods: A questionnaire consisting of 14 questions was sent to directors of 18 main pediatric oncology centers in the Nordic countries in 2010 and 2022. We received information regarding indications, guidelines, counseling, and available fertility preservation options.
Results: The response rates were 89% in 2010 and 72% in 2022. The results reveal an increase in clinical practice guidelines on fertility preservation for cancer patients, from 25% in 2010 to 70% in 2022. Counseling on fertility preservation options in 2022 was more specific and offered to most patients who fulfilled indications for fertility preservation (from 19 to 77%). Sperm cryopreservation continues to be the predominant fertility preservation method for pubertal boys in the Nordic countries. However, there has been a notable increase in the availability of testicular tissue preservation for prepubertal boys (0 to 62%). A similar increase in the offer of ovarian tissue preservation for prepubertal girls (0 to 92%) was observed among pediatric cancer patients.
Conclusions: The past decade has shown commendable advancements in fertility preservation for pediatric cancer patients in the Nordic countries.
Implications for cancer survivors: As fertility care evolves globally, continuous assessment of regional practices and challenges is imperative to enhance the quality of care and life for pediatric cancer survivors in the Nordic regions.
Keywords: Cancer; Children; Fertility; Fertility preservation; Oncology; Pediatric; Questionnaire.
© 2024. The Author(s).
Similar articles
-
Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries - compilation of 20 years of multicenter experience.Acta Obstet Gynecol Scand. 2016 Sep;95(9):1015-26. doi: 10.1111/aogs.12934. Epub 2016 Jul 3. Acta Obstet Gynecol Scand. 2016. PMID: 27258933 Free PMC article.
-
Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort.Hum Reprod. 2023 Mar 1;38(3):359-370. doi: 10.1093/humrep/dead004. Hum Reprod. 2023. PMID: 36708005 Free PMC article.
-
Fertility preservation in pediatric healthcare: a review.Front Endocrinol (Lausanne). 2023 May 3;14:1147898. doi: 10.3389/fendo.2023.1147898. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37206440 Free PMC article. Review.
-
Practices of pediatric oncology and hematology providers regarding fertility issues: a European survey.Pediatr Blood Cancer. 2014 Nov;61(11):2054-8. doi: 10.1002/pbc.25163. Epub 2014 Jul 25. Pediatr Blood Cancer. 2014. PMID: 25065353
-
[Fertility preservation in oncology].Bull Cancer. 2018 Jan;105(1):99-110. doi: 10.1016/j.bulcan.2017.11.001. Epub 2017 Dec 6. Bull Cancer. 2018. PMID: 29221621 Review. French.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous